Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada
-
* Corresponding author: Gord Blackhouse blackhou@mcmaster.ca
Cost Effectiveness and Resource Allocation 2010, 8:14 doi:10.1186/1478-7547-8-14
Accesses
- Last 30 days: 185 accesses
- Last 365 days: 2297 accesses
- All time: 6317 accesses